Loading…
2 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Sport-Kompleksi Saguramo | Fitness & Wellness | -115.8% | 13th pct | 30 |
| Abreshumis Gzis Corpora… | (unclassified) | -240.3% | 3rd pct | 1208 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
| Ratio — FY 2024 | Abreshumis Gzis Corpora… | Sport-Kompleksi Saguramo |
|---|---|---|
| Margins | ||
| Gross Margin | 100.0% | 48.6% |
| EBITDA Margin | -240.3% | -115.8% |
| EBITDAR | -1,953 | -306 |
| EBITDAR Margin | -240.3% | -115.8% |
| EBIT Margin | -242.0% | -210.2% |
| Net Profit Margin | -456.2% | -446.9% |
| Operating Expense % of Sales | 340.3% | 164.5% |
| Returns | ||
| Return on Assets (ROA) | -557.4% | -17.1% |
| Return on Equity (ROE) | N/A | N/A |
| ROIC [EBIT / Invested Capital] | -448.9% | -8.3% |
| Leverage & debt balances | ||
| Debt-to-Assets | 3208.2% | 142.6% |
| Debt-to-Equity | -1.02x | -3.15x |
| Debt-to-EBITDA | N/A | N/A |
| Equity-to-Assets | -3135.7% | -45.3% |
| Net Debt | 21,293 | 9,840 |
| Cash & Equivalents | 44 | 17 |
| Total Debt | 21,337 | 9,856 |
| Liquidity & working capital | ||
| Current Ratio | 0.03x | 1.73x |
| Quick Ratio | 0.03x | 1.73x |
| Cash Ratio | 0.00x | 0.00x |
| Total Current Assets | 612 | 6,440 |
| Total Current Liabilities | 21,520 | 3,728 |
| Inventory | N/A | N/A |
| Trade Receivables | 337 | 372 |
| Trade Payables | 179 | 186 |
| Net Working Capital | -20,909 | 2,712 |
| Net Working Capital % of Revenue | -2573.2% | 1025.6% |
| Trade Working Capital | 158 | 186 |
| Trade Working Capital % of Revenue | 19.5% | 70.3% |
| Change in Trade Working Capital | N/A | N/A |
| Turnover & efficiency | ||
| Inventory Turnover | N/A | N/A |
| Days Inventory Outstanding (DIO) | N/A | N/A |
| Receivables Turnover | 2.41x | 0.71x |
| Days Sales Outstanding (DSO) | 151.5 | 513.6 |
| Payables Turnover | N/A | 0.73x |
| Days Payable Outstanding (DPO) | N/A | 500.7 |
| Cash Conversion Cycle | 151.5 days | 12.9 days |
| Asset Turnover | 1.22x | 0.04x |
| Cash flow & dividends | ||
| Operating Cash Flow | N/A | N/A |
| Free Cash Flow (OCF − Capex proxy) | N/A | N/A |
| Cash Conversion (OCF / EBITDA) | N/A | N/A |
| Dividends Declared | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A |